View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsBhang 과거 순이익 실적과거 기준 점검 0/6지난 몇 년간 Bhang 의 실적에 대한 데이터가 부족합니다.핵심 정보n/a순이익 성장률n/a주당순이익(EPS) 성장률Personal Products 산업 성장률35.82%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Sep 2022최근 과거 실적 업데이트Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.004 loss per share (vs US$0.003 loss in 3Q 2021)Third quarter 2022 results: US$0.004 loss per share (further deteriorated from US$0.003 loss in 3Q 2021). Revenue: US$363.1k (up 28% from 3Q 2021). Net loss: US$901.3k (loss widened 31% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 30Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: US$300.3k (down 7.9% from 2Q 2021). Net loss: US$1.10m (loss widened 49% from 2Q 2021).Reported Earnings • Jun 02Full year 2021 earnings released: US$0.017 loss per share (vs US$0.032 loss in FY 2020)Full year 2021 results: US$0.017 loss per share (up from US$0.032 loss in FY 2020). Revenue: US$1.27m (down 22% from FY 2020). Net loss: US$3.30m (loss narrowed 25% from FY 2020).Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$283.0k (up 7.4% from 3Q 2020). Net loss: US$688.5k (loss narrowed 47% from 3Q 2020). Revenue was in line with analyst estimates.Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$326.2k (up 3.4% from 2Q 2020). Net loss: US$736.2k (loss narrowed 34% from 2Q 2020).모든 업데이트 보기Recent updatesReported Earnings • Dec 01Third quarter 2022 earnings released: US$0.004 loss per share (vs US$0.003 loss in 3Q 2021)Third quarter 2022 results: US$0.004 loss per share (further deteriorated from US$0.003 loss in 3Q 2021). Revenue: US$363.1k (up 28% from 3Q 2021). Net loss: US$901.3k (loss widened 31% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Paul Pellegrini was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Oct 27Bhang Inc. Announces Changes to Board of DirectorsBhang Inc. announced that Jessica Billingsley and Andrea L. Johnston have resigned from their respective positions as Directors of the Company. The Company is also announced that it has appointed Sara Lee Irwin and Paul Pellegrini to its Board of Directors. Ms. Irwin is a nationally recognized public voice on cannabis and cannabinoids for therapeutic use. With over decades of experience as both an industry consultant and chronic pain patient, Sara has leveraged her personal experience to become a leading representative and liaison working to bridge interests across multiple stakeholder groups, including patients, physicians, researchers, the pharmaceutical industry, investors, institutional brokers, and government. An early advocate of the benefits of the pharmaceutical application of cannabinoids, Ms. Irwin was the Director of Investor Relations at Cannasat Therapeutics between 2004 - 2010, an early-stage cannabinoid pharmaceutical company that, in 2006, became the first publicly traded herbal cannabis company in North America. Ms. Irwin was a founding director of Miraculo Inc., an integrated media, technology and consumer product company in the medical cannabis and CBD industry which was recently acquired by Trees Corporation, a premier Canadian cannabis retailer. Mr. Pellegrini is the Executive Chairman and Founder of Sussex Strategy Group. He brings a track record of proven success in strategic consulting based on direct government experience and his relationship-building expertise. In 1990, as President of HealthWatch, Mr. Pellegrini began providing strategic consulting services to clients in the public and private sectors on a wide variety of business, government relations and public affairs matters. Mr. Pellegrini's expertise in issues management, crisis communications, and stakeholder relations was called upon to serve in a variety of senior roles in federal and provincial ministerial offices. Subsequent to his tenure in the public sector, Mr. Pellegrini founded Sussex in 1998. Mr. Pellegrini currently serves on the Campaign Cabinet for the new Vaughan hospital and sits on the Board of Directors for CHAR Technologies. He is recognized as an active community leader advocating for numerous non-profit and charitable causes. Often interviewed for his insights into current government issues, Mr. Pellegrini has been a political commentator on CP24.Reported Earnings • Aug 30Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: US$300.3k (down 7.9% from 2Q 2021). Net loss: US$1.10m (loss widened 49% from 2Q 2021).공고 • Aug 11+ 1 more updateBhang Inc. Announces Executive ChangesBhang Inc. announced the resignation of CEO, Jamie L. Pearson, who has been with the Company since 2015 and has served as President of the brand since 2019. A nationwide search for Pearson's replacement is expected to begin shortly. In the meantime, Graham Simmonds will assume the role of interim CEO. Simmonds is also the Chairman of Plant-Based Investment Corp. In addition to holding multiple Board seats on Canadian-listed publicly traded companies, Simmonds is also an experienced CEO and entrepreneur.공고 • Jun 15Bhang Inc. Launches High Roller Nano-Infused Pre-RollBhang Inc. ('Bhang' or the 'Company') is complementing its strong position in the cannabis edibles market with the launch of a new, innovative pre-roll offering. The new Bhang High Roller Nano-infused Pre-Roll is a whole flower product combined with nano-THC that delivers a more effective, efficient, and consistent experience. Since 2010, the Company has focused on building a legacy around providing its customers with precise, consistent cannabis chocolate products, perfecting a recipe with Bhang's signature cannabis-free taste, and the best premium ingredients. Bhang High Roller Nano-infused Pre-Rolls add to the Company's legacy of effectiveness and consistency, produced with quality infused flower that is precisely dosed, just like Bhang's chocolates. The new infused pre-roll consists of hand-selected premium indoor flower combined with nano-THC coming in consistently at 50+% THC (20% more than their standard pre-roll), delivering a stronger and more enjoyable high. Nano-THC means the THC particles themselves are smaller, meaning the High Roller Pre-Roll is infused with tiny molecules making the THC easier to absorb, facilitating almost instant onset. The Bhang High Roller nano-infused pre-roll is available in 1 gram format, delivering a 50+% THC dosage carefully rolled in unbleached natural brown papers. The new product offering was mentioned in Bhang's recent Petalfast announcement and will be a significant part of the partnership kickoff, and is now ready to be sold in California dispensaries.Reported Earnings • Jun 02Full year 2021 earnings released: US$0.017 loss per share (vs US$0.032 loss in FY 2020)Full year 2021 results: US$0.017 loss per share (up from US$0.032 loss in FY 2020). Revenue: US$1.27m (down 22% from FY 2020). Net loss: US$3.30m (loss narrowed 25% from FY 2020).Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Chairman of Board Graham Simmonds was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Recent Insider Transactions Derivative • Jan 08Director exercised options to buy CA$80k worth of stock.On the 31st of December, Daniel Nauth exercised options to buy 937k shares at a strike price of around CA$0.077, costing a total of CA$72k. This transaction amounted to 180% of their direct individual holding at the time of the trade. Daniel currently holds less than 1% of total shares outstanding. Company insiders have collectively bought CA$137k more than they sold, via options and on-market transactions, in the last 12 months.공고 • Dec 19Bhang Inc. announced that it has received CAD 1.218107 million in fundingBhang Inc. announced a non-brokered private placement of 22,147,400 units at a price of CAD 0.055 per unit for gross proceeds of CAD 1,218,107 on December 17, 2021. Each unit consists of one subordinate voting common share and one half of common share purchase warrant. Each warrant can be exercised to acquire one common share at a price of CAD 0.1 per share for a period of 18 months from the date of closing. The securities are being subject to four months and one day hold period expiring on April 18, 2022. In connection with the transaction, the company paid, to a finder, a cash commission of approximately CAD 25,014 in relation to the gross proceeds of the transaction raised from subscribers introduced to the company by such finder. The company also issued an aggregate of 454,800 finder warrants to the finder with each finder warrant entitling the holder thereof to acquire one common share at an exercise price of CAD 0.10 for a period of 18 months following the closing of the transaction.Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$283.0k (up 7.4% from 3Q 2020). Net loss: US$688.5k (loss narrowed 47% from 3Q 2020). Revenue was in line with analyst estimates.Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$326.2k (up 3.4% from 2Q 2020). Net loss: US$736.2k (loss narrowed 34% from 2Q 2020).공고 • Mar 23Bhang Inc. announced that it has received CAD 1.770613 million in funding from Plant-Based Investment Corp. and other investorsOn March 22, 2021, Bhang Inc. (CNSX:BHNG) closed the transaction. The company issued 27,240,192 subordinate voting shares for gross proceeds of CAD 1,770,612 in the transaction. The company issued 16,853,615 subordinate voting shares for gross proceeds of CAD 1,095,485 in its second and final tranche. In connection with this tranche, the company paid, to certain eligible finders, a cash commission of approximately CAD 16,587 in relation to the gross proceeds raised from subscribers introduced to the company by such finders. The subordinate voting shares issued in connection with the second tranche are subject to a statutory four month and one day hold period expiring on July 23, 2021, and such further restrictions as may apply under foreign securities laws.공고 • Mar 07Bhang Inc. announced that it expects to receive CAD 2 million in funding from Plant-Based Investment Corp. and other investorsBhang Inc. (CNSX:BHNG) announced non-brokered private placement of 30,769,231 subordinate voting shares at a price of CAD 0.065 per share for gross proceeds of CAD 2,000,000 on March 5, 2021. On the same date, the company issued 10,386,577 subordinate voting shares for gross proceeds of CAD 675,128 in its first tranche. The tranche included participation from returning investor Plant-Based Investment Corp. (CNSX:PBIC) for 3,846,154 subordinate voting shares for CAD 250,000 to own 50.42% stake upon closing of first tranche. The shares issued are subject to hold period expiring on July 6, 2021.공고 • Jan 31Bhang Announces Board and Executive ChangesBhang Inc. announced that its board of directors has appointed Graham Simmonds as a director of the Company following the resignation of Nick J. Richards, effective January 28, 2021. Mr. Simmonds was also appointed as Executive Chair of the board of directors and Daniel Nauth, the Company's former Chairman, continues to serve as a director of the Company. Mr. Simmonds was nominated as a director by Plant-Based Investment Corp. ("PBIC") pursuant to a subscription agreement between the Company and PBIC dated February 10, 2020, whereby PBIC has the right to appoint a nominee to the Company's board of directors. Mr. Simmonds currently serves as Chair of PBIC and was formerly Executive Vice Chair of Bhang in 2020. Mr. Simmonds is an entrepreneur with a diverse background in consumer-driven businesses. He has founded and taken public three companies over the past 15 years in the gaming, cannabis and financial technology sectors. Mr. Simmonds has over 20 years of general experience in public company management and business development projects within the gaming, technology and other regulated sectors. He is also licensed and/or has previously been licensed/registered with a number of horse racing and gaming commissions in the United States and Canada. Mr. Simmonds is the founder and former Chairman and CEO of CordovaCann Corp., and DealNet Capital Corp. Graham currently serves as a director and/or officer to a number of public companies including Baymount Incorporated, Prime City One Capital Corp., Aion Therapeutic Inc. and Plant-Based Investment Corp. Mr. Simmonds also formerly served as a director and as Executive Vice Chair of the Company in 2020.공고 • Nov 25Bhang Inc. Announces Director ChangesBhang Inc. announced that at the annual and special meeting held on November 24, 2020, it has approved election of Andrea Johnston and Jessica Billingsley to serve as directors of the Company and to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. The Company announced that William J. Waggoner, did not stand for re-election as a director.공고 • Oct 11Bhang Announces Board ChangesBhang Inc. announced the Company's board of directors has accepted the resignation of Graham Simmonds and has appointed Nick J. Richards to fill the board vacancy. Mr. Richards was nominated as a director by Cannabis Growth Opportunity Corporation pursuant to a subscription agreement between the Company and CGOC dated February 10, 2020, whereby CGOC has the right to appoint a nominee to the Company's board of directors. Mr. Richards is a Partner in the tax and cannabis practice groups at Greenspoon Marder LLP. As a former IRS trial attorney, he represents individuals and businesses in tax audits and trials, M&A, managing tax debt, and he advises cannabis companies, both owners and investors, regarding tax and regulatory compliance matters. In addition, he is widely recognized as a leading cannabis industry attorney and has extensive experience in IRC Section 280E and BSA cash reporting requirements. Mr. Richards is also an adjunct professor of law, proud father, husband, and a founding director of CGOC.공고 • Aug 06An unknown buyer acquired 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel for CAD 0.32 million.An unknown buyer acquired 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel for CAD 0.32 million on July 30, 2020. Scott J. Van Rixel sold 0.02 million multiple voting shares at a price of CAD 14.75 per share. Scott J. Van Rixel now owns 0.01 million multiple voting shares of Bhang representing approximately 16.32% of that class on an undiluted and diluted basis. Scott J. Van Rixel also has post conversion beneficial ownership of 12.3 million subordinate voting shares of Bhang. An unknown buyer completed the acquisition of 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel on July 30, 2020.매출 및 비용 세부 내역Bhang가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이CNSX:BHNG 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비30 Sep 221-55030 Jun 221-45031 Mar 221-44031 Dec 211-34030 Sep 211-23030 Jun 211-43031 Mar 211-44031 Dec 202-44030 Sep 202-65030 Jun 203-138031 Mar 204-148031 Dec 195-138030 Sep 195-117030 Jun 194-34031 Mar 193-13031 Dec 182-23031 Dec 172-120양질의 수익: BHNG가 고품질 수익을 갖고 있는지 판단하기에는 데이터가 부족합니다.이익 마진 증가: 지난 1년 동안 BHNG의 이익률이 개선되었는지 판단하기에 데이터가 부족합니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 BHNG의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: BHNG의 지난해 수익 성장률을 5년 평균과 비교하기에 데이터가 부족합니다.수익 대 산업: BHNG의 지난 해 수익 증가율이 Personal Products 업계 평균을 상회했는지 판단하기에 데이터가 부족합니다.자기자본이익률높은 ROE: BHNG는 현재 수익성이 없으므로 자본 수익률이 음수(0%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YHousehold 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/07/06 19:28종가2024/04/08 00:00수익2022/09/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Bhang Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.004 loss per share (vs US$0.003 loss in 3Q 2021)Third quarter 2022 results: US$0.004 loss per share (further deteriorated from US$0.003 loss in 3Q 2021). Revenue: US$363.1k (up 28% from 3Q 2021). Net loss: US$901.3k (loss widened 31% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 30Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: US$300.3k (down 7.9% from 2Q 2021). Net loss: US$1.10m (loss widened 49% from 2Q 2021).
Reported Earnings • Jun 02Full year 2021 earnings released: US$0.017 loss per share (vs US$0.032 loss in FY 2020)Full year 2021 results: US$0.017 loss per share (up from US$0.032 loss in FY 2020). Revenue: US$1.27m (down 22% from FY 2020). Net loss: US$3.30m (loss narrowed 25% from FY 2020).
Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$283.0k (up 7.4% from 3Q 2020). Net loss: US$688.5k (loss narrowed 47% from 3Q 2020). Revenue was in line with analyst estimates.
Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$326.2k (up 3.4% from 2Q 2020). Net loss: US$736.2k (loss narrowed 34% from 2Q 2020).
Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.004 loss per share (vs US$0.003 loss in 3Q 2021)Third quarter 2022 results: US$0.004 loss per share (further deteriorated from US$0.003 loss in 3Q 2021). Revenue: US$363.1k (up 28% from 3Q 2021). Net loss: US$901.3k (loss widened 31% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Paul Pellegrini was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Oct 27Bhang Inc. Announces Changes to Board of DirectorsBhang Inc. announced that Jessica Billingsley and Andrea L. Johnston have resigned from their respective positions as Directors of the Company. The Company is also announced that it has appointed Sara Lee Irwin and Paul Pellegrini to its Board of Directors. Ms. Irwin is a nationally recognized public voice on cannabis and cannabinoids for therapeutic use. With over decades of experience as both an industry consultant and chronic pain patient, Sara has leveraged her personal experience to become a leading representative and liaison working to bridge interests across multiple stakeholder groups, including patients, physicians, researchers, the pharmaceutical industry, investors, institutional brokers, and government. An early advocate of the benefits of the pharmaceutical application of cannabinoids, Ms. Irwin was the Director of Investor Relations at Cannasat Therapeutics between 2004 - 2010, an early-stage cannabinoid pharmaceutical company that, in 2006, became the first publicly traded herbal cannabis company in North America. Ms. Irwin was a founding director of Miraculo Inc., an integrated media, technology and consumer product company in the medical cannabis and CBD industry which was recently acquired by Trees Corporation, a premier Canadian cannabis retailer. Mr. Pellegrini is the Executive Chairman and Founder of Sussex Strategy Group. He brings a track record of proven success in strategic consulting based on direct government experience and his relationship-building expertise. In 1990, as President of HealthWatch, Mr. Pellegrini began providing strategic consulting services to clients in the public and private sectors on a wide variety of business, government relations and public affairs matters. Mr. Pellegrini's expertise in issues management, crisis communications, and stakeholder relations was called upon to serve in a variety of senior roles in federal and provincial ministerial offices. Subsequent to his tenure in the public sector, Mr. Pellegrini founded Sussex in 1998. Mr. Pellegrini currently serves on the Campaign Cabinet for the new Vaughan hospital and sits on the Board of Directors for CHAR Technologies. He is recognized as an active community leader advocating for numerous non-profit and charitable causes. Often interviewed for his insights into current government issues, Mr. Pellegrini has been a political commentator on CP24.
Reported Earnings • Aug 30Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: US$300.3k (down 7.9% from 2Q 2021). Net loss: US$1.10m (loss widened 49% from 2Q 2021).
공고 • Aug 11+ 1 more updateBhang Inc. Announces Executive ChangesBhang Inc. announced the resignation of CEO, Jamie L. Pearson, who has been with the Company since 2015 and has served as President of the brand since 2019. A nationwide search for Pearson's replacement is expected to begin shortly. In the meantime, Graham Simmonds will assume the role of interim CEO. Simmonds is also the Chairman of Plant-Based Investment Corp. In addition to holding multiple Board seats on Canadian-listed publicly traded companies, Simmonds is also an experienced CEO and entrepreneur.
공고 • Jun 15Bhang Inc. Launches High Roller Nano-Infused Pre-RollBhang Inc. ('Bhang' or the 'Company') is complementing its strong position in the cannabis edibles market with the launch of a new, innovative pre-roll offering. The new Bhang High Roller Nano-infused Pre-Roll is a whole flower product combined with nano-THC that delivers a more effective, efficient, and consistent experience. Since 2010, the Company has focused on building a legacy around providing its customers with precise, consistent cannabis chocolate products, perfecting a recipe with Bhang's signature cannabis-free taste, and the best premium ingredients. Bhang High Roller Nano-infused Pre-Rolls add to the Company's legacy of effectiveness and consistency, produced with quality infused flower that is precisely dosed, just like Bhang's chocolates. The new infused pre-roll consists of hand-selected premium indoor flower combined with nano-THC coming in consistently at 50+% THC (20% more than their standard pre-roll), delivering a stronger and more enjoyable high. Nano-THC means the THC particles themselves are smaller, meaning the High Roller Pre-Roll is infused with tiny molecules making the THC easier to absorb, facilitating almost instant onset. The Bhang High Roller nano-infused pre-roll is available in 1 gram format, delivering a 50+% THC dosage carefully rolled in unbleached natural brown papers. The new product offering was mentioned in Bhang's recent Petalfast announcement and will be a significant part of the partnership kickoff, and is now ready to be sold in California dispensaries.
Reported Earnings • Jun 02Full year 2021 earnings released: US$0.017 loss per share (vs US$0.032 loss in FY 2020)Full year 2021 results: US$0.017 loss per share (up from US$0.032 loss in FY 2020). Revenue: US$1.27m (down 22% from FY 2020). Net loss: US$3.30m (loss narrowed 25% from FY 2020).
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Chairman of Board Graham Simmonds was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions Derivative • Jan 08Director exercised options to buy CA$80k worth of stock.On the 31st of December, Daniel Nauth exercised options to buy 937k shares at a strike price of around CA$0.077, costing a total of CA$72k. This transaction amounted to 180% of their direct individual holding at the time of the trade. Daniel currently holds less than 1% of total shares outstanding. Company insiders have collectively bought CA$137k more than they sold, via options and on-market transactions, in the last 12 months.
공고 • Dec 19Bhang Inc. announced that it has received CAD 1.218107 million in fundingBhang Inc. announced a non-brokered private placement of 22,147,400 units at a price of CAD 0.055 per unit for gross proceeds of CAD 1,218,107 on December 17, 2021. Each unit consists of one subordinate voting common share and one half of common share purchase warrant. Each warrant can be exercised to acquire one common share at a price of CAD 0.1 per share for a period of 18 months from the date of closing. The securities are being subject to four months and one day hold period expiring on April 18, 2022. In connection with the transaction, the company paid, to a finder, a cash commission of approximately CAD 25,014 in relation to the gross proceeds of the transaction raised from subscribers introduced to the company by such finder. The company also issued an aggregate of 454,800 finder warrants to the finder with each finder warrant entitling the holder thereof to acquire one common share at an exercise price of CAD 0.10 for a period of 18 months following the closing of the transaction.
Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$283.0k (up 7.4% from 3Q 2020). Net loss: US$688.5k (loss narrowed 47% from 3Q 2020). Revenue was in line with analyst estimates.
Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$326.2k (up 3.4% from 2Q 2020). Net loss: US$736.2k (loss narrowed 34% from 2Q 2020).
공고 • Mar 23Bhang Inc. announced that it has received CAD 1.770613 million in funding from Plant-Based Investment Corp. and other investorsOn March 22, 2021, Bhang Inc. (CNSX:BHNG) closed the transaction. The company issued 27,240,192 subordinate voting shares for gross proceeds of CAD 1,770,612 in the transaction. The company issued 16,853,615 subordinate voting shares for gross proceeds of CAD 1,095,485 in its second and final tranche. In connection with this tranche, the company paid, to certain eligible finders, a cash commission of approximately CAD 16,587 in relation to the gross proceeds raised from subscribers introduced to the company by such finders. The subordinate voting shares issued in connection with the second tranche are subject to a statutory four month and one day hold period expiring on July 23, 2021, and such further restrictions as may apply under foreign securities laws.
공고 • Mar 07Bhang Inc. announced that it expects to receive CAD 2 million in funding from Plant-Based Investment Corp. and other investorsBhang Inc. (CNSX:BHNG) announced non-brokered private placement of 30,769,231 subordinate voting shares at a price of CAD 0.065 per share for gross proceeds of CAD 2,000,000 on March 5, 2021. On the same date, the company issued 10,386,577 subordinate voting shares for gross proceeds of CAD 675,128 in its first tranche. The tranche included participation from returning investor Plant-Based Investment Corp. (CNSX:PBIC) for 3,846,154 subordinate voting shares for CAD 250,000 to own 50.42% stake upon closing of first tranche. The shares issued are subject to hold period expiring on July 6, 2021.
공고 • Jan 31Bhang Announces Board and Executive ChangesBhang Inc. announced that its board of directors has appointed Graham Simmonds as a director of the Company following the resignation of Nick J. Richards, effective January 28, 2021. Mr. Simmonds was also appointed as Executive Chair of the board of directors and Daniel Nauth, the Company's former Chairman, continues to serve as a director of the Company. Mr. Simmonds was nominated as a director by Plant-Based Investment Corp. ("PBIC") pursuant to a subscription agreement between the Company and PBIC dated February 10, 2020, whereby PBIC has the right to appoint a nominee to the Company's board of directors. Mr. Simmonds currently serves as Chair of PBIC and was formerly Executive Vice Chair of Bhang in 2020. Mr. Simmonds is an entrepreneur with a diverse background in consumer-driven businesses. He has founded and taken public three companies over the past 15 years in the gaming, cannabis and financial technology sectors. Mr. Simmonds has over 20 years of general experience in public company management and business development projects within the gaming, technology and other regulated sectors. He is also licensed and/or has previously been licensed/registered with a number of horse racing and gaming commissions in the United States and Canada. Mr. Simmonds is the founder and former Chairman and CEO of CordovaCann Corp., and DealNet Capital Corp. Graham currently serves as a director and/or officer to a number of public companies including Baymount Incorporated, Prime City One Capital Corp., Aion Therapeutic Inc. and Plant-Based Investment Corp. Mr. Simmonds also formerly served as a director and as Executive Vice Chair of the Company in 2020.
공고 • Nov 25Bhang Inc. Announces Director ChangesBhang Inc. announced that at the annual and special meeting held on November 24, 2020, it has approved election of Andrea Johnston and Jessica Billingsley to serve as directors of the Company and to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. The Company announced that William J. Waggoner, did not stand for re-election as a director.
공고 • Oct 11Bhang Announces Board ChangesBhang Inc. announced the Company's board of directors has accepted the resignation of Graham Simmonds and has appointed Nick J. Richards to fill the board vacancy. Mr. Richards was nominated as a director by Cannabis Growth Opportunity Corporation pursuant to a subscription agreement between the Company and CGOC dated February 10, 2020, whereby CGOC has the right to appoint a nominee to the Company's board of directors. Mr. Richards is a Partner in the tax and cannabis practice groups at Greenspoon Marder LLP. As a former IRS trial attorney, he represents individuals and businesses in tax audits and trials, M&A, managing tax debt, and he advises cannabis companies, both owners and investors, regarding tax and regulatory compliance matters. In addition, he is widely recognized as a leading cannabis industry attorney and has extensive experience in IRC Section 280E and BSA cash reporting requirements. Mr. Richards is also an adjunct professor of law, proud father, husband, and a founding director of CGOC.
공고 • Aug 06An unknown buyer acquired 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel for CAD 0.32 million.An unknown buyer acquired 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel for CAD 0.32 million on July 30, 2020. Scott J. Van Rixel sold 0.02 million multiple voting shares at a price of CAD 14.75 per share. Scott J. Van Rixel now owns 0.01 million multiple voting shares of Bhang representing approximately 16.32% of that class on an undiluted and diluted basis. Scott J. Van Rixel also has post conversion beneficial ownership of 12.3 million subordinate voting shares of Bhang. An unknown buyer completed the acquisition of 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel on July 30, 2020.